Claglid MV 0.3mg/500mg/60mg Tablet
Marketer
Proqol Healthcare
Salt Composition
Voglibose (0.3mg) + Metformin (500mg) + Gliclazide (60mg)
Overview Claglid MV 0.3mg/500mg/60mg Tablet
Diabex Trio 0.3mg/500mg/60mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabex Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood glucose response. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing a healthy diet, regular exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, vomiting, diarrhea, abdominal pain, headache, edema, blurred vision, and bone fractures. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Claglid MV 0.3mg/500mg/60mg Tablet
Managing Type 2 diabetes
Major Benefits of Claglid MV 0.3mg/500mg/60mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Claglid MV 0.3mg/500mg/60mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Claglid MV 0.3mg/500mg/60mg Tablet:
- Nausea
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Constipation
How to use Claglid MV 0.3mg/500mg/60mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Claglid MV 0.3mg/500mg/60mg Tablet with a meal.
How Claglid MV 0.3mg/500mg/60mg Tablet works:
One tablet of Claglid MV contains a triple-action antidiabetic formula, combining 0.3mg, 500mg, and 60mg of three distinct medications.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Claglid MV 0.3mg/500mg/60mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Claglid MV 0.3mg/500mg/60mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is advised.
Breast feedingCAUTION
Administering Claglid MV 0.3mg/500mg/60mg tablets to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued for the duration of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Claglid MV 0.3mg/500mg/60mg tablets cautiously, potentially requiring dosage modification. Consult a physician. The medication is contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Claglid MV 0.3mg/500mg/60mg tablets cautiously, potentially requiring dose modification. Individuals with severe liver disease should avoid this medication. A lower starting dose is typically advised for those with mild to moderate hepatic dysfunction. Medical consultation is recommended.
What if you forget to take Claglid MV 0.3mg/500mg/60mg Tablet :
NA
Facts to Know About Claglid MV 0.3mg/500mg/60mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently